BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34450166)

  • 1. DPP4 inhibitor reduces portal hypertension in cirrhotic rats by normalizing arterial hypocontractility.
    Wang X; Gu H; Li K; Lin J; Zhu Y; Deng W
    Life Sci; 2021 Nov; 284():119895. PubMed ID: 34450166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactive oxygen species are involved in regulating hypocontractility of mesenteric artery to norepinephrine in cirrhotic rats with portal hypertension.
    Chen W; Liu DJ; Huo YM; Wu ZY; Sun YW
    Int J Biol Sci; 2014; 10(4):386-95. PubMed ID: 24719556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of soluble epoxide hydrolase reduces portal pressure by protecting mesenteric artery myogenic responses in cirrhotic rats.
    Huang Y; Qin J; Sun D; Jiang H; Zheng L; He Y; Gui L; Qian B; Zhang C; Luo M
    Prostaglandins Other Lipid Mediat; 2017 Jul; 131():17-24. PubMed ID: 28473204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desensitization of G-protein-coupled receptors induces vascular hypocontractility in response to norepinephrine in the mesenteric arteries of cirrhotic patients and rats.
    Chen W; Sang JY; Liu DJ; Qin J; Huo YM; Xu J; Wu ZY
    Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):295-304. PubMed ID: 23742775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of soluble epoxide hydrolase lowers portal hypertension in cirrhotic rats by ameliorating endothelial dysfunction and liver fibrosis.
    Deng W; Zhu Y; Lin J; Zheng L; Zhang C; Luo M
    Prostaglandins Other Lipid Mediat; 2017 Jul; 131():67-74. PubMed ID: 28822809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of epoxyeicosatrienoic acid production in rats with cirrhosis has beneficial effects on portal hypertension by reducing splanchnic vasodilation.
    Di Pascoli M; Zampieri F; Verardo A; Pesce P; Turato C; Angeli P; Sacerdoti D; Bolognesi M
    Hepatology; 2016 Sep; 64(3):923-30. PubMed ID: 27312119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased myoendothelial gap junctions mediate the enhanced response to epoxyeicosatrienoic acid and acetylcholine in mesenteric arterial vessels of cirrhotic rats.
    Bolognesi M; Zampieri F; Di Pascoli M; Verardo A; Turato C; Calabrese F; Lunardi F; Pontisso P; Angeli P; Merkel C; Gatta A; Sacerdoti D
    Liver Int; 2011 Jul; 31(6):881-90. PubMed ID: 21645220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NADPH oxidase 1/4 inhibition attenuates the portal hypertensive syndrome via modulation of mesenteric angiogenesis and arterial hyporeactivity in rats.
    Deng W; Duan M; Qian B; Zhu Y; Lin J; Zheng L; Zhang C; Qi X; Luo M
    Clin Res Hepatol Gastroenterol; 2019 Jun; 43(3):255-265. PubMed ID: 30413372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoaction.
    Moleda L; Trebicka J; Dietrich P; Gäbele E; Hellerbrand C; Straub RH; Sauerbruch T; Schoelmerich J; Wiest R
    Gut; 2011 Aug; 60(8):1122-32. PubMed ID: 21317421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyphenol-Rich Blackcurrant Juice Prevents Endothelial Dysfunction in the Mesenteric Artery of Cirrhotic Rats with Portal Hypertension: Role of Oxidative Stress and the Angiotensin System.
    Rashid S; Idris-Khodja N; Auger C; Kevers C; Pincemail J; Alhosin M; Boehm N; Oswald-Mammosser M; Schini-Kerth VB
    J Med Food; 2018 Apr; 21(4):390-399. PubMed ID: 29569976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen improves the hyperdynamic circulation and hyporeactivity of mesenteric arteries by alleviating oxidative stress in partial portal vein ligated rats.
    Zhang B; Zhang CG; Zhou QB; Chen W; Wu ZY
    World J Gastroenterol; 2013 Oct; 19(40):6863-8. PubMed ID: 24187462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin reverses major portal hypertension-related derangements in rats with liver cirrhosis and diabetes.
    Hsin IF; Huang HC; Chang CC; Hsu SJ; Lee FY; Huo TI; Chuang CL; Hou MC; Lee SD
    Clin Sci (Lond); 2018 Nov; 132(22):2391-2405. PubMed ID: 30348829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of Splenic Resistance Arteries to Splanchnic Blood Overflow in Cirrhosis.
    Turkseven S; Bolognesi M; Di Pascoli M
    Dig Dis Sci; 2021 Mar; 66(3):796-801. PubMed ID: 32242304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender differences in vascular reactivity of mesenteric arterioles in portal hypertensive and non-portal hypertensive rats.
    Zhang B; Ji LH; Zhang CG; Zhao G; Wu ZY
    World J Gastroenterol; 2019 Oct; 25(39):5953-5960. PubMed ID: 31660032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Nuclear Factor-E2-related factor 2/Heme Oxygenase 1 on splanchnic hemodynamics in experimental cirrhosis with portal hypertension.
    Qin J; He Y; Duan M; Luo M
    Microvasc Res; 2017 May; 111():12-19. PubMed ID: 28025064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human manganese superoxide dismutase reduces liver fibrosis and portal pressure in CCl4-cirrhotic rats.
    Guillaume M; Rodriguez-Vilarrupla A; Gracia-Sancho J; Rosado E; Mancini A; Bosch J; Garcia-Pagán JC
    J Hepatol; 2013 Feb; 58(2):240-6. PubMed ID: 22989570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dipeptidyl peptidase-4 inhibition on portal hypertensive and cirrhotic rats.
    Huang HC; Hsu SJ; Chuang CL; Hsiung SY; Chang CC; Hou MC; Lee FY
    J Chin Med Assoc; 2021 Dec; 84(12):1092-1099. PubMed ID: 34670224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The beneficial effects of curcumin in cirrhotic rats with portal hypertension.
    Hsu SJ; Lee JY; Lin TY; Hsieh YH; Huang HC; Lee FY; Lin HC; Hou MC; Lee SD
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29162665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrogen sulfide attenuates carbon tetrachloride-induced hepatotoxicity, liver cirrhosis and portal hypertension in rats.
    Tan G; Pan S; Li J; Dong X; Kang K; Zhao M; Jiang X; Kanwar JR; Qiao H; Jiang H; Sun X
    PLoS One; 2011; 6(10):e25943. PubMed ID: 22022478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dipeptidyl peptidase 4 inhibition on arterial blood pressure is context dependent.
    Jackson EK; Mi Z; Tofovic SP; Gillespie DG
    Hypertension; 2015 Jan; 65(1):238-49. PubMed ID: 25368027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.